Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma
- PMID: 14612902
- PMCID: PMC2394459
- DOI: 10.1038/sj.bjc.6601359
Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma
Abstract
Renal cell carcinomas, although usually apparently fully resected at surgery, commonly recur as distant metastasis. New markers are needed to predict which patients may relapse especially as novel methods of treatment (e.g. laproscopic resection) may make it impossible to assess conventional pathological prognostic markers. The caveolins are a family of proteins that represent the major structural components of caveolae; recent work suggests that these may have influence on several signalling pathways and they are thus potential prognostic markers. Immunohistochemistry for caveolin-1 was performed on sections of peripheral tumour from 114 consecutative nonmetastatic RCCs. Cytoplasmic caveolin-1 immunohistochemical (ICC) reaction was scored on a semiquantative scale of 1-3. Immunohistochemical score was tested for impact on disease-free survival by Kaplan-Meier and Cox regression methods. A total of 50 tumours had ICC score 1; 43 had score 2 and 21 score 3. Larger, higher grade and tumours with vascular invasion had significantly higher scores. On univariate survival analysis (Kaplan-Meier), patients with tumours scoring 1 had a mean disease-free survival of 6.61 years (95% CI 5.76-7.46) compared with 5.4 years (4.53-6.30) and 3.15 years (1.87-4.44) for scores 2 and 3, respectively. This is a significant difference (P=0.0017 log rank test). On multivariate analysis with size, grade and caveolin ICC score as independent covariates, caveolin ICC score 3 was an influential predictor of poor disease-free survival with a hazard ratio of 2.6 (P=0.03). We conclude that cytoplasmic overexpression of caveolin-1 predicts a poor prognosis in RCC; that this is likely to be a useful prognostic marker and that it may have importance in tumour progression.
Figures


Similar articles
-
Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease.J Transl Med. 2013 Oct 11;11:255. doi: 10.1186/1479-5876-11-255. J Transl Med. 2013. PMID: 24119769 Free PMC article.
-
Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma.Br J Cancer. 2008 Mar 11;98(5):931-40. doi: 10.1038/sj.bjc.6604243. Epub 2008 Feb 19. Br J Cancer. 2008. PMID: 18283322 Free PMC article.
-
Prognostic implications of the immunohistochemical expression of human kallikreins 5, 6, 10 and 11 in renal cell carcinoma.Tumour Biol. 2006;27(1):1-7. doi: 10.1159/000090150. Epub 2005 Dec 8. Tumour Biol. 2006. PMID: 16340244
-
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.Dan Med J. 2017 Oct;64(10):B5339. Dan Med J. 2017. PMID: 28975890
-
Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.Urology. 2004 Apr;63(4):651-5. doi: 10.1016/j.urology.2003.11.011. Urology. 2004. PMID: 15072872
Cited by
-
Prognostic value of caveolin-1 in genitourinary cancer: a meta-analysis.Int J Clin Exp Med. 2015 Nov 15;8(11):20760-8. eCollection 2015. Int J Clin Exp Med. 2015. PMID: 26884999 Free PMC article.
-
Genomics of renal cell cancer-- does it provide breakthrough?Pathol Oncol Res. 2006;12(1):5-11. doi: 10.1007/BF02893425. Epub 2006 Mar 23. Pathol Oncol Res. 2006. PMID: 16554910 Review.
-
Caveolin-1 in renal cell carcinoma promotes tumour cell invasion, and in co-operation with pERK predicts metastases in patients with clinically confined disease.J Transl Med. 2013 Oct 11;11:255. doi: 10.1186/1479-5876-11-255. J Transl Med. 2013. PMID: 24119769 Free PMC article.
-
Genetic Variants in Caveolin-1 and RhoA/ROCK1 Are Associated with Clear Cell Renal Cell Carcinoma Risk in a Chinese Population.PLoS One. 2015 Jun 12;10(6):e0128771. doi: 10.1371/journal.pone.0128771. eCollection 2015. PLoS One. 2015. PMID: 26066055 Free PMC article. Clinical Trial.
-
Nucleostemin mRNA is expressed in both normal and malignant renal tissues.Br J Cancer. 2006 Jun 5;94(11):1658-62. doi: 10.1038/sj.bjc.6603145. Br J Cancer. 2006. PMID: 16670719 Free PMC article.
References
-
- Bagnoli M, Tomassetti A, Figini M, Flati S, Dolo V, Canevari S, Miotti S (2000) Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression. Oncogene 19: 4754–4763 - PubMed
-
- Campbell L, Laidler P, Watson RE, Kirby B, Griffiths CE, Gumbleton M (2002) Downregulation and altered spatial pattern of caveolin-1 in chronic plaque psoriasis. Br J Dermatol 147: 701–709 - PubMed
-
- Cao G, Yang G, Timme TL, Saika T, Truong LD, Satoh T, Goltsov A, Park SH, Men T, Kusaka N, Tian W, Ren C, Wang H, Kadmon D, Cai WW, Chinault AC, Boone TB, Bradley A, Thompson TC (2003) Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. Am J Pathol 162: 1241–1248 - PMC - PubMed
-
- Dekel Y, Koren R, Kugel V, Livne PM, Gal R (2002) Significance of angiogenesis and microvascular invasion in renal cell carcinoma. Pathol Oncol Res 8: 129–132 - PubMed
-
- Dhote R, Pellicer-Coeuret M, Thiounn N, Debre B, Vidal-Trecan G (2000) Risk factors for adult renal cell carcinoma: a systematic review and implications for prevention. BJU Int 86: 20–27 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical